Expert in Vaccines, IVD, Animal Health, Coronavirus Virus and Vaccine Models
Expert ID: 722023 South Dakota, USA
Expert has worked extensively in reducing bacterial toxins in final biologic products through process control, downstream processing and toxin measurements.
He directed a division at SmithKline Beecham Animal Health on biologic response modifiers, adjuvants and delivery systems. Through his efforts, new materials were added to the veterinary and human biologics programs. In his consulting practice, Expert works with clients on various modifier and immune enhancers for disease prevention, treatment and vaccine augmentations.
Expert has been a scientific business manager for over 21 years. He has directed staffs up to 37 scientists and controlled a total budget of $7.5 million (operating, contingency and capital expenditures). He presently serves on the Board of Directors of ImmuCell Corporation where he contributes his business management skills to the biotech organization.
Expert is a seasoned professional in vaccination. He has licensed products which encompass cutting edge technologies, as well as market-proven older concepts. He was the first researcher to license a live recombinant virus for domestic animal use. He holds international patents on feline leukemia vaccines as well as rabies immunoenhancers. And he has worked with vaccines of various presentations (live, inactivated, vectored, synthetics and DNA) and for various species.
Expert helped design a new virus production facility for client. He also has experience designing a new animal holding facility.
He regularly does on-site in-depth R&D projects, on-site troubleshooting of biological processes, and on-site project management and project reviews.
|Year: 1978||Degree: Ph.D.||Subject: Veterinary Virology and Immunology||Institution: University of Massachusetts Amherst|
|Year: 1976||Degree: M.S.||Subject: Veterinary Virology and Immunology||Institution: UMass Amherst|
|Year: 1974||Degree: B.A.||Subject: Biology||Institution: Boston University|
|Years: 1992 to Present||Employer: Undisclosed||Title: President||Department:||Responsibilities: As president of his own private practice, Expert is responsible for the daily operations of the company as well as principal consultant on biotech project management and strategic alliances.|
|Years: 1985 to 1992||Employer: SmithKline Beecham Animal Health||Title: Director, Virology and Immunology Development||Department: R&D||Responsibilities: He was responsible for two research divisions in animal vaccines development at SmithKline, and for regulatory affairs and marketing support.|
|Years: 1984 to 1985||Employer: TechAmerica||Title: Project Leader||Department: R&D||Responsibilities: He led an R&D team that focused on IVD antigen production and animal vaccine development.|
|Years: 1980 to 1984||Employer: Sanofi, S.A.||Title: Manager, Avian Vaccine Development||Department: R&D||Responsibilities: He was responsible for vaccine development and the diagnostic division of the company.|
|Years: 1975 to 1978||Agency: USDA||Role: Hatch Grant||Description: Expert performed research on the role of oncogenic herpesviruses in poultry.|
|Years||Country / Region||Summary|
|Years: to Present||Country / Region: Czech Republic||Summary: In the Czech Republic, Expert assisted with a strategic partnering and transfer of technology to a U.S. partner.|
|Years: 2007 to 2007||Country / Region: South Africa||Summary: He did a complete site audit and process improvement program for a veterinary vaccine manufacturer|
|Years: 2009 to Present||Country / Region: Ethiopia||Summary: He conducted a complete site audit, implemented new production process and down stream processing methods for the State Veterinary Institute.|
|Years: 1996 to 1998||Country / Region: Australia||Summary: Expert assisted in FDA assessment of a new hormone vaccine product for the U.S. market.|
|Years: to Present||Country / Region: Canada||Summary: He collaborated on new vaccine delivery systems.|
|Associations / Societies|
|Expert is a member of the United States Animal Health Association (USAHA): committee Chair Biologics and Biotechnology, the American Association of Veterinary Laboratory Diagnosticians (AAVLD), the American Society for Microbiology (ASM), AAALS, and the Conference of Research Workers in Animal Diseases (CRWAD).|
|Expert was a Board Member for ImmuCell Corporation (Nasdaq: ICCC), a biotechnology company focused on the development and marketing of animal health products, targeting the bovine industry, the dairy and beef industry.|
|Medical / Professional|
|He was a Postdoctoral Fellow at Purdue University School of Veterinary Medicine, 1978-1980.|
|Publications and Patents Summary|
|Expert has over 40 U.S. and 55 international license registrations, more than 25 publications and two international patents.|
|Expert Witness Experience|
|Expert has been an expert witness for the U.S. government in a federal court case. He has been an expert witness on two occasions for a Fortune 50 company.|
|Training / Seminars|
|Expert developed and presents the seminar, "Smart Starts mean Fast Finishes - Biological Development."|
|He routinely helps source vendors and supplies for his clients.|
|He has worked with domestic and international marketing groups in bringing 40 products to market in the U.S., and 55 internationally.|
|Other Relevant Experience|
|Expert possesses extensive experience in project management, especially keeping R&D projects on schedule. Additionally, he is considered by his peers and clients to be a bright, realistic scientist who knows what is required to license a product. He can design the experiments required for licensure without going overboard on costs, and can confidently defend the data to the licensing authorities.|
|French||Basic conversation (tourist level).|
Fields of Expertise
animal vaccine, artificial animal vaccine, bacterial disease, bacterial toxin, bacterial vaccine, biologic (product), biological response modifier, business management, cellular immunity, Chlamydia bacterium, disease control, immunologic adjuvant, Microsoft Project Manager, project management, research and development management, vaccination, veterinary virology, infectious disease